There are 2867 resources available
146P - HRD/TIL-low high-risk breast cancer is characterized by good prognosis (the RADIMMUNE trial)
Presenter: Benedetta Pellegrino
Session: Poster session 01
147P - Blind validation of an AI-based tool for predicting distant relapse from breast cancer HES stained slides
Presenter: Ingrid Garberis
Session: Poster session 01
148P - Serum metabolomics based risk assessment of disease recurrence in elderly patients with early breast cancer (eBC)
Presenter: Emanuela Risi
Session: Poster session 01
149P - Clinical outcomes in ER+ breast cancer patients with recurrence score 26-30-guided therapy: Real-world data
Presenter: Ofer Rotem
Session: Poster session 01
150P - Assessment of high Ki67 (≥20%) ER+HER2- breast cancer with a 21-gene multigene assay
Presenter: Sung Gwe Ahn
Session: Poster session 01
151P - Tumor biology and immunology in patients (pts) with breast cancer occurring during pregnancy (BCP) compared to non-pregnant breast cancer pts
Presenter: Kristin Galas
Session: Poster session 01
152P - Molecular characterization by the 21-gene breast cancer (BC) Recurrence Score (RS) test of BRCA1/2 mutation carriers (mBRCA1/2) versus the general BC patient (pt) population
Presenter: Rinat Yerushalmi
Session: Poster session 01
153P - HER2DX risk-score in the context of the PREDICT online-tool: A correlative analysis of the Short-HER clinical trial in early-stage HER2-positive (HER2+) breast cancer (BC)
Presenter: Pier Franco Conte
Session: Poster session 01
154P - Prognosis of pregnancy after breast cancer diagnosis according to the type of treatment: A population-based study in Korea by the SMARTSHIP group
Presenter: Sungmin Park
Session: Poster session 01